Nausea and Vomiting in Pregnancy (NVP) & Hyperemesis Gravidarum
RCOG Green-top Guideline No. 69 The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum. Last revised: Jun 2025.
NICE CKS Nausea / vomiting in pregnancy. Last revised: Apr 2025.
Background Information
Definition
Nausea and vomiting in pregnancy (NVP): nausea and/or vomiting during pregnancy that begins <16 weeks of gestation, provided no other causes are present
Hyperemesis gravidarum is a severe form of NVP, where nausea and/or vomiting are severe enough to cause:
- An inability to eat and drink normally, and
- Strong limitations on daily activities of living
Epideimology
Mild to moderate NVP is very common and can be considered a normal, physiological part of pregnancy. It affects up to 90% of pregnant women.
Mild to moderate NVP does not negatively impact the developing fetus and may even have a protective effect on the pregnancy.
Aetiology
The primary cause of NVP and hyperemesis gravidarum is linked to hypersensitivty to GDF-15 – a vomiting hormone produced when placental genes are activated
- hCG is no longer believed to be the causative factor
- GDF-15 is responsible for causing taste aversion, loss of appetite, nausea, vomiting, and weight loss
Key risk factors:
- Genetic factors (variations affecting the expression of the GDF-15)
- Previous history of NVP or hyperemesis gravidarum
- Multiple pregnancies (e.g. twins)
- Trophoblastic disease (including molar pregnancy and choriocarcinoma)
- Chronic H. pylori infection
Clinical Features
NVP and hyperemesis gravidarum usually begin at 4-7 weeks of gestation and peak at ~9 weeks. Symptoms usually resolve by 20 weeks (in ~90% women).
Symptoms:
- Nausea
- Vomiting
- Inability to tolerate food and fluids
- Hypersalivation and spitting
Complications
Metabolic complications
- Dehydration (e.g. tachycardia, hypotension, tachypnoea, dry lips and mouth, oliguria or anuria)
- Weight loss
- Electrolyte imbalance – hyponatraemia, hypokalemia, metabolic hypochloraemic alkalosis
- Acute kidney injury
- Nutritional and vitamin deficiencies
- Vitamin B1 deficiency → life-threatening Wernicke’s encephalopathy
- Vitamin B6 and B12 deficiency → peripheral neuropathy
Complications of severe vomiting:
- Retinal haemorrhage
- Mallory-Weiss tears / oesophageal rupture
- Pneumothorax / pneumomediastinum
- Splenic avulsion
- GORD / oesophagitis, gastritis
Diagnosis
Diagnostic Criteria
NVP and hyperemesis gravidarum are clinical diagnoses, supported by biochemical findings listed below.
Traditionally, hyperemesis gravidarum is characterised by the triad of 1) ≥5% weight loss 2) dehydration 3) electrolyte disturbances
Latest guideline is now considered a clinical diagnosis
- NVP hyperemesis gravidarum shares the same symptoms, but hyperemesis gravidarum is severe enough to impact daily activities and quality of life
- Signs of dehydration are considered a contributory factor to the diagnosis of HG, which is uncommon in typical, uncomplicated NVP
The traditional triad can help identify HG, but is no longer required for diagnosis.
Investigation and Assessment
History and clinical examination should include:
- Temperature, blood pressure, pulse, oxygen saturation, respiratory rate, and weight
- Abdominal and neurological examination
Recommended investigations:
- Urinalysis (if urinalysis indicates UTI → send MSU)
- Blood tests
- FBC
- U&E
- Blood glucose
- Ultrasound – to confirm a viable intrauterine pregnancy and assess for multiple pregnancy / trophoblastic disease
- Consider TFT, LFT, amylase, calcium, phosphate and venous blood gas in refractory cases / history of previous admissions
Biochemical findings and trends:
| Test | Finding / trends |
|---|---|
| Urinalysis | Ketonuria is often present
RCOG strongly emphasise that ketonuria is NOT an indicator of dehydration and should not be used to assess the severity of NVP or hyperemesis gravidarum. |
| FBC | Raised haematocrit and haemoglobin (from dehydration) |
| U&E | Electrolytes
Renal function
|
| Venous blood gas | Hypochloraemia, metabolic alkalosis |
Severity Assessment
The Pregnancy-Unique Quantification of Emesis (PUQE) tool can be used to classify the severity:
- ≤6 = mild
- 7-12 = moderate
- 13-15 = severe
Management
Admission Criteria
Inpatient care should be considered if ANY of the following is present:
- PUQE score ≥13
- Failed outpatient management
Refer for inpatient management if ANY of the following is present:
- Inability to tolerate oral intake
- Clinical dehydration
- >5% weight loss despite oral antiemetics
- Presence of co-morbidities (e.g. epilepsy, diabetes, HIV, hypoadrenalism, psychiatric disease)
- Concerns regarding mental health
Inpatient vs Outpatient Care
Inpatient care should involve:
- Rehydration with IV 0.9% saline with additional potassium (dextrose is NOT recommended)
- Thiamine supplementation (oral or Pabrinex®)
- Thromboprophylaxis with LMWH (alternative: graduated compression stockings)
If inpatient care is not indicated, offer the following conservative care as an outpatinet@
- Rest as needed
- Avoid sensory stimuli (e.g. odours, heat, noise)
- Eat plain biscuits / crackers in the morning
- Bland, small, frequent protein-rich meals, low in carbohydrate and fat
- Drink little and often
- Acupressure (e.g., over P6 point)
Apart from those above, see the anti-emetic therapy section below, which should be offered in both inpatient and outpatinet care.
Anti-Emetic Therapy
Most of the following can be given orally or parenterally (IM / IV / SC); the route of administration depends on outpatient vs inpatient management.
Stepping up anti-emetics:
- If the patient does not respond to a single antiemetic, the guideline recommends combining drugs from different classes
- If the 1st line options are ineffective (even after combinations) → step up by adding 2nd line medications
Many women will require a combination of two or more medications from both the 1st and 2nd line options
| 1st line options | Antihistamines
Phenothiazines:
|
| 2nd line options | Ondansetron (very small risk of orofacial clefting in 1st trimester, but should not be discouraged if 1st line failed)
Dopamine antagonists
|
| 3rd line options | Corticosteroids (IV hydrocortisone or oral prednisolone) – to be used in combination with other antiemetics |
References